+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Obesity Surgery Devices Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 194 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968782
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The obesity surgery devices market is experiencing notable evolution as healthcare systems adapt to greater clinical demand with advanced, minimally invasive technologies. Decision-makers require actionable intelligence to respond strategically and maintain a clear edge in a constantly shifting global landscape.

Market Snapshot: Obesity Surgery Devices Market

The global obesity surgery devices market is expanding steadily, with its robust growth propelled by an increasing rate of surgical interventions for obesity-related conditions and relentless advancements in device capabilities. As device manufacturers continuously integrate innovative solutions and healthcare environments diversify, the sector maintains a positive long-term forecast. Strong compound annual growth and widespread adoption across both established and emerging medical settings continue to enhance market momentum. The field benefits from dynamic shifts in clinical protocols and rapid uptake of new technological standards, generating new opportunities for differentiation and competitive agility.

Scope & Segmentation of the Obesity Surgery Devices Market

This comprehensive report provides senior leaders with clear segmentation and strategic clarity across the obesity surgery devices industry, supporting a granular view of growth factors and innovation priorities within global and regional contexts.

  • Procedure Types: Adjustable gastric banding restricts patient food intake, gastric bypass modifies the digestive path for long-term weight management, and sleeve gastrectomy reduces stomach size to promote sustained weight loss outcomes.
  • Device Types: Cutting and stapling devices support efficient procedures, endoscopic devices offer minimally invasive solutions (including innovative stapling and suturing options), implants enable adaptable patient management, and advanced visualization equipment boosts intraoperative safety and precision.
  • Technologies: Laparoscopic systems deliver faster recovery and fewer complications, open procedures remain vital for complex cases, and robotic platforms (multi-arm or single-port) help surgeons achieve greater control and image clarity.
  • End Users: Ambulatory surgical centers handle high-volume and lower-acuity cases, hospitals (public and private) manage comprehensive obesity procedures, and specialty clinics focus on ongoing bariatric care.
  • Regional Coverage: Insights extend to the Americas (including United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru), Europe, Middle East & Africa (covering principal European and Middle Eastern markets, and Africa), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan).
  • Featured Companies: Johnson & Johnson, Medtronic plc, Becton, Dickinson and Company, Intuitive Surgical, Inc., Stryker Corporation, Olympus Corporation, Smith & Nephew plc, CONMED Corporation, Boston Scientific Corporation, and Teleflex Incorporated.

Key Takeaways for Strategic Planning

  • Minimally invasive procedures are at the forefront, increasing demand for obesity surgery devices built on next-generation technology that prioritizes patient safety, clinical effectiveness, and short recovery periods.
  • Major device manufacturers are diversifying product portfolios with cutting-edge cutting and stapling systems, enhanced endoscopic suturing, advanced implants, and sophisticated visualization to support surgical precision.
  • Sector-wide collaboration with medical experts and integration of real-world data are refining product development, ensuring that device innovation remains in alignment with medical standards and regulatory shifts.
  • The adoption of robotics and digital health, such as AI-enabled analytics and remote monitoring, is influencing how perioperative and post-surgical care is delivered, supporting new standards for quality and oversight.
  • Supply chain resilience is now a strategic imperative, as nearshoring, renegotiation with suppliers, and robust procurement strategies are helping the sector adapt to evolving trade realities and ensure reliable device availability.

Tariff Impact on the Obesity Surgery Devices Market

Recent U.S. tariffs have resulted in higher import costs for essential device components. As a response, manufacturers and distributors are shifting toward regionalized sourcing and investing more in domestic production capabilities. Healthcare providers are addressing short-term price volatility with group purchasing strategies and contractual adjustments, while device suppliers are developing domestic partnerships and enhancing quality assurance to reinforce competitiveness and safeguard supply continuity.

Methodology & Data Sources

This analysis integrates rigorous secondary research, including peer-reviewed scientific literature, regulatory evaluations, and technology reviews. Primary perspectives from interviews with bariatric surgeons, senior industry executives, and supply chain specialists ensure the report reflects up-to-date expert insights, validated by thorough review and reliability checks.

Why This Report Matters for Senior Leaders

  • Empowers targeted investment and procurement strategies through segmented evaluation of technologies, clinical procedures, and geographical regions.
  • Informs executive planning with timely insights on regulatory evolution, tariff effects, and optimization strategies throughout complex supply chains in the obesity surgery devices market.
  • Delivers actionable clinical and market analyses to support strategic agility in dynamic healthcare environments.

Armed with robust analytics and expert clinical insights, this report enables executive teams to shape proactive strategies and secure competitive positioning in a transforming obesity surgery devices sector.

Conclusion

Ongoing demand, regulatory development, and persistent innovation steer the direction of obesity surgery devices. Timely market intelligence equips industry leaders to sustain growth and strengthen their strategic position over the long term.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Increased adoption of robotic-assisted laparoscopic instruments for complex sleeve gastrectomy procedures
5.2. Development of bioresorbable gastric implants designed to minimize chronic foreign body reaction risks
5.3. Expansion of endoscopic transoral sleeve gastroplasty devices enabling outpatient weight loss interventions
5.4. Integration of sensor-enabled intragastric balloons for real-time monitoring of gastric pressure and volume
5.5. Emergence of dual-function intragastric balloons combining mechanical restriction with peptide hormone delivery capabilities
5.6. Adoption of 3D printing for patient-specific gastric bands and stents to optimize fit and reduce complication rates
5.7. Use of telehealth-connected wearable monitoring systems to track postoperative weight loss and nutritional compliance
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Obesity Surgery Devices Market, by Procedure Type
8.1. Adjustable Gastric Banding
8.2. Gastric Bypass
8.3. Sleeve Gastrectomy
9. Obesity Surgery Devices Market, by Device Type
9.1. Cutting And Stapling Devices
9.2. Endoscopic Devices
9.2.1. Stapling Devices
9.2.2. Suturing Devices
9.3. Implants
9.3.1. Band Systems
9.3.2. Port Systems
9.4. Visualization Systems
10. Obesity Surgery Devices Market, by Technology
10.1. Laparoscopic
10.2. Open
10.3. Robotic
10.3.1. Multi Arm
10.3.2. Single Port
11. Obesity Surgery Devices Market, by End User
11.1. Ambulatory Surgical Centers
11.2. Hospitals
11.2.1. Private Hospitals
11.2.2. Public Hospitals
11.3. Specialty Clinics
12. Obesity Surgery Devices Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Obesity Surgery Devices Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Obesity Surgery Devices Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Johnson & Johnson
15.3.2. Medtronic plc
15.3.3. Becton, Dickinson and Company
15.3.4. Intuitive Surgical, Inc.
15.3.5. Stryker Corporation
15.3.6. Olympus Corporation
15.3.7. Smith & Nephew plc
15.3.8. CONMED Corporation
15.3.9. Boston Scientific Corporation
15.3.10. Teleflex Incorporated
List of Tables
List of Figures

Samples

Loading
LOADING...

Companies Mentioned

The key companies profiled in this Obesity Surgery Devices market report include:
  • Johnson & Johnson
  • Medtronic plc
  • Becton, Dickinson and Company
  • Intuitive Surgical, Inc.
  • Stryker Corporation
  • Olympus Corporation
  • Smith & Nephew plc
  • CONMED Corporation
  • Boston Scientific Corporation
  • Teleflex Incorporated

Table Information